Lataa...
Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer
Mortality rates for ovarian cancer have declined only slightly in the past forty years since the “War on Cancer” was declared. The current standard care of ovarian cancer is still cytoredutive surgery followed by several cycles of chemotherapy. The severe adverse effect from chemotherapy drug is a l...
Tallennettuna:
| Julkaisussa: | J Control Release |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632596/ https://ncbi.nlm.nih.gov/pubmed/28847739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2017.08.028 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|